10 CFR 26.121
§ 26.121 Purpose.
United States · 10 CFR — Energy · Status: effective
Cite this
- Citation
- 10 CFR 26.121, § 26.121 Purpose, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/36671
- Permanent ID
ys:prov:36671@1- SHA-256
23236683077b39aa444c6db5b724b1985d7afa56ad0c2bf5c5749e15601d9d44
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
This subpart contains requirements for facilities that are operated by licensees and other entities who are subject to this part to perform initial tests of urine specimens for validity, drugs, and drug metabolites. This subpart shall cease to have effect on January 8, 2027, unless the NRC determines that the cessation deadline should be extended to a date not more than 5 years in the future after offering the public an opportunity to provide input on the costs and benefits of this subpart and considering that input. The NRC will publish a document in the Federal Register announcing its determination and revising or removing this subpart accordingly.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.